No Data
No Data
No Data
No Data
No Data
Some Investors May Be Willing To Look Past Pro-Dex's (NASDAQ:PDEX) Soft Earnings
Pro-Dex, Inc.'s (NASDAQ:PDEX) earnings announcement last week didn't impress shareholders. While the headline numbers were soft, we believe that investors might be missing some encouraging factors.
Simply Wall StFeb 16 14:36 ET
Pro-Dex Q2 EPS $0.14, Sales $12.59M Beat $11.50M Estimate
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.35 by 60 percent. This is a 41.67 percent decrease over earnings of $0.24 per sha
BenzingaFeb 8 16:58 ET
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersXilio Therapeutics (NASDAQ:XLO) shares rose 10.5% to $0.66 during Thursday's after-market session. The market value of their outstanding shares is at $18.2 million. Sensus Healthcare (NASDAQ:SR
BenzingaFeb 8 16:31 ET
Earnings Flash (PDEX) PRO-DEX Reports Q2 Revenue $12.6M
04:02 PM EST, 02/08/2024 (MT Newswires) -- Earnings Flash (PDEX) PRO-DEX Reports Q2 Revenue $12.6M
MT NewswiresFeb 8 16:02 ET
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
IRVINE, CA / ACCESSWIRE / February 8, 2024 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. The Company also filed its Quar
AccesswireFeb 8 16:00 ET
Pro-Dex, Inc. (NASDAQ:PDEX) Surges 27% Yet Its Low P/E Is No Reason For Excitement
Pro-Dex, Inc. (NASDAQ:PDEX) shareholders have had their patience rewarded with a 27% share price jump in the last month. Looking further back, the 24% rise over the last twelve months isn't too bad
Simply Wall StJan 26 05:21 ET
No Data
No Data